Contact Us
Drug Search Results
More Filters [+]

Prochlorperazine

Alternative Names: prochlorperazine, compazine, compro, procomp
Latest Update: 2024-12-24
Latest Update Note: Clinical Trial Update

Product Description

Prochlorperazine is used to treat nervous, emotional, and mental conditions (eg, schizophrenia) and non-psychotic anxiety. It is also used to control severe nausea and vomiting. This medicine should not be used to treat behavioral problems in older adult patients who have dementia. (Sourced from: https://www.mayoclinic.org/drugs-supplements/prochlorperazine-oral-route/side-effects/drg-20406263?p=1)

Mechanisms of Action: D2 Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous,Oral,Inhalant

FDA Designation: None *

Approval Status: Approved

Approved Countries: Australia | Bangladesh | Canada | Cyprus | Egypt | Finland | Hong Kong | India | Ireland | Italy | Lebanon | Malaysia | Malta | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Romania | Singapore | South Africa | Sri Lanka | Sweden | Taiwan | Ukraine | United Kingdom | United States | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Prochlorperazine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title

09/23/2024

News Article

 Avenacy to Share Company's Year One Progress at CPHI Milan 2024

07/26/2024

News Article

 Motion Sickness Drugs Market size is set to grow by USD 139.5 million from 2024-2028, Availability of over-the-counter (OTC) drugs to boost the market growth, Technavio

07/18/2024

News Article

 Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules to Ease Administration for Patients Experiencing Dysphagia or Difficulty Swallowing

06/26/2024

News Article

 Avenacy Announces Launch of Prochlorperazine Edisylate Injection, USP in the U.S. Market

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions